OrthoPediatrics Corp Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- OrthoPediatrics Corp share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2020-12-31 was 670.00 shares.
- OrthoPediatrics Corp share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2020-09-30 was 11.23K shares, a 35.87% decline year-over-year.
- OrthoPediatrics Corp share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2020-06-30 was 19.16K shares, a 542.59% increase year-over-year.
- OrthoPediatrics Corp share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2020-03-31 was 22.21K shares, a 20.52% increase year-over-year.
- OrthoPediatrics Corp share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 670.00 shares, a 66.67% decline from fiscal 2022.
- OrthoPediatrics Corp share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2022 was 2.01K shares, a 54.55% decline from fiscal 2021.
- OrthoPediatrics Corp share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2021 was 4.42K shares, a 91.70% decline from fiscal 2020.
- OrthoPediatrics Corp share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2020 was 53.27K shares, a 36.87% increase from fiscal 2019.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2023-12-31 | 670.00 shares 10-K · filed 2026-03-04 | |
| 2022-12-31 | 2.01K shares 10-K · filed 2025-03-05 | |
| 2021-12-31 | 4.42K shares 10-K · filed 2024-03-08 | |
| 2020-12-31 | 670.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | 53.27K shares 10-K · filed 2023-03-01 |
| 2020-09-30 | 11.23K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | 52.60K shares derived: sum of 4 quarters · filed 2022-03-03 |
| 2020-06-30 | 19.16K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | 58.88K shares derived: sum of 4 quarters · filed 2022-03-03 |
| 2020-03-31 | 22.21K shares 10-Q · filed 2020-05-06 | 42.70K shares derived: sum of 4 quarters · filed 2022-03-03 |
| 2019-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | 38.92K shares 10-K · filed 2022-03-03 |
| 2019-09-30 | 17.51K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | 41.60K shares derived: sum of 4 quarters · filed 2021-03-11 |
| 2019-06-30 | 2.98K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-13 | |
| 2019-03-31 | 18.43K shares 10-Q · filed 2019-05-09 | |
| 2018-12-31 | 2.68K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | 14.21K shares 10-K · filed 2021-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| CARLSMED, INC. (CARL) | United States | $0.405B |